MAPK14 and cancer: Recently, evidence has emerged that flavopereirine, a chemotherapeutic agent that decreases the proliferation and viability of cancer cells largely through unknown mechanisms, inhibited autophagy by upregulating the P38 MAPK pathway (Chen et al., 2020).